Company Day One Biopharmaceuticals, Inc.
Equities
DAWN
US23954D1090
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.57 USD | -0.68% | +33.01% | +20.34% |
29/04 | North American Morning Briefing : Investors Brace -2- | DJ |
24/04 | Needham Adjusts Price Target on Day One Biopharmaceuticals to $33 From $30, Keeps Buy Rating | MT |
Business Summary
Number of employees: 155
Managers
Managers | Title | Age | Since |
---|---|---|---|
Samuel Blackman
FOU | Founder | 55 | 01/18/01 |
Jeremy Bender
CEO | Chief Executive Officer | 52 | 01/20/01 |
Charles York
DFI | Director of Finance/CFO | 47 | 01/21/01 |
Mike Pregih
CTO | Chief Tech/Sci/R&D Officer | - | - |
Adam Dubow
CMP | Compliance Officer | 57 | 01/22/01 |
Davy Chiodin
PRN | Corporate Officer/Principal | - | - |
Lauren Merendino
PRN | Corporate Officer/Principal | 49 | 01/23/01 |
Jaa Roberson
HRO | Human Resources Officer | - | 13/21/13 |
Raphaël Rousseau
PRN | Corporate Officer/Principal | 55 | 01/23/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
J. Garland
BRD | Director/Board Member | 55 | 17/21/17 |
Natalie Holles
BRD | Director/Board Member | 51 | 01/21/01 |
John Josey
BRD | Director/Board Member | 63 | 01/20/01 |
Jeremy Bender
CEO | Chief Executive Officer | 52 | 01/20/01 |
Director/Board Member | 37 | 01/19/01 | |
Director/Board Member | 48 | 01/21/01 | |
William Grossman
BRD | Director/Board Member | 54 | 17/01 |
Garry Nicholson
CHM | Chairman | 69 | 12/22/12 |
Habib Dable
BRD | Director/Board Member | 54 | 17/01 |
Dan Becker
BRD | Director/Board Member | 49 | 01/19/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 87,377,163 | 70,029,780 ( 80.15 %) | 0 | 80.15 % |
Company contact information
Day One Biopharmaceuticals, Inc.
2000 Sierra Point Parkway Suite 501
94005, Brisbane
+
http://www.dayonebio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.34% | 1.55B | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- DAWN Stock
- Company Day One Biopharmaceuticals, Inc.